RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...

SINGING has provided a soundtrack to human history. Songs tell people about their past and their values. Ancient epics, which ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the second patient has been treated ...

Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter ...

( NewsNation) — Prisha Mosley, a North Carolina woman who detransitioned after transitioning as a teen, said her appeal in a ...

The ACT for ALS Reauthorization Act passed Congress on September 28, and Gail Kim credited Tanea "Rebel" Brooks and the ...

The New Era of Tumor-Agnostic Cancer Therapy / ALK, Allen Chen, BCR ABL, Bence Jones proteins, biomarkers, BRAF, CA 19-9, ...

Advances in early diagnosis and cancer treatment mean that growing numbers of people are surviving cancer, with approximately 3.5 million people now living with and beyond the disease in the United ...

One-time infusion using CRISPR may permanently lower LDL cholesterol, reducing the risk of heart attack, stroke.

From Andy Pandy onwards, children’s TV has been an apolitical sanctuary where parents can relax, knowing their little ones ...

Concoria Parish Academy freshman Destineé Davis scored a 20 on the ACT after eighth grade, exceeding the national average as ...